Association of Fibrinogen with Glycemic Control and Albumin Excretion Rate in Patients with Non-Insulin-Dependent Diabetes Mellitus

Annals of Internal Medicine

Volumn 125, Issue 8, 1996, Pages 653-657

  Bruno, Graziella ^a   Cavallo Perin, Paolo ^a   Bargero, Giuseppe ^b   Borra, Milena ^a   D'Errico, Nicola ^a   Pagano, Gianfranco ^a  

^a Dipartimento di Medicina Interna   (Italy)

^b Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ALBUMINURIA; ARTERIOSCLEROSIS; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; RISK FACTOR; URINE;

ADULT; AGED; ALBUMINURIA; ARTERIOSCLEROSIS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOGEN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030587837     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-8-199610150-00005     Document Type: Article

References (20)

1. Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemost. 1988;14:189-95.
2. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-63.
3. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk Results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-9.
4. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1996;332:635-41.
5. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J. 1990;120:672-6.
6. Lee AJ, Lowe GD, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J. 1993;69:338-42.
7. Ganda OP, Arkin CF. Hyperfibrirogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care. 1992;15:1245-50.
8. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GD, et al. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes. 1992;41:909-13.
9. Schmitz A, Ingerslev J. Haemostatic measures in type 2 diabetic patients with microalbuminuria. Diabet Med. 1990;7:521-5.
10. Knobl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36:1045-50.
11. Mattock MB, Keen H, Viberti GC, el-Gohari MR, Murrells TJ, Scott GS, et al. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1988;31:82-7.
12. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care. 1993;16:996-1003.
13. Bruno G, Bargero G, Vuolo A, Pisu E, Pagano G. A population-based prevalence survey of known diabetes mellitus in Northern Italy based upon multiple independent sources of ascertainment. Diabetologia. 1992;35:851-6.
14. Bruno G, LaPorte RE, Merletti F, Biggeri A, McCarty D, Pagano G. National diabetes programs. Application of capture-recapture to count diabetes? Diabetes Care. 1994;17:548-56.
15. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, et al. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care. 1996;19:43-6.
16. Clauss A. Measurement of fibrinogen. Acta Haematol. 1957;17:237-42.
17. De Feo P, Gaisano MG, Haymond MW. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest. 1991;88:833-40.
18. Ceriello A. Hemostatic abnormalities in diabetes mellitus: consequence of hyperglycemia. Nutrition, Metabolism, and Cardiovascular Diseases. 1995;5: 237-40
19. Ceriello A, Taboga C, Giacomello R, Falleti E, De Stasio G, Motz S, et al. Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes. 1994;43:430-2.
20. Pagano G, Bargero G, Vuolo A, Bruno G. Prevalence and clinical features of known type 2 diabetes in the elderly: a population-based study. Diabet Med. 1993;11:475-9.